
Dufour
@dufour_jf
Liver Specialist
ID: 2867174649
http://www.swissliver.ch 08-11-2014 11:20:46
431 Tweet
1,1K Followers
140 Following

Prof Bataller sharing his experience in alcohol-associated liver disease Ramon Bataller Susana Rodrigues


Pegozafermin effects on top of GLP-1 therapy Rohit Loomba Swiss NASH Foundation EASL Education




#GUTImage from the paper by Cho, Ang and Quek et al entitled "Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis" via bit.ly/3rOKMot Aung Hlaing Bwa MBBS, FRCP Anand V Kulkarni Karn Wijarnpreecha Rohit Loomba


#GUTAbstract by Zhang & Terry Cheuk-Fung Yip on "Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation..." via bit.ly/49b1uz4 Paper: bit.ly/49aAArq Grace Wong Lee-Ling Lim Vincent Wong



#GUTImage from the paper by Evelyn Medawar et al on "Prebiotic diet changes neural correlates of food decision-making in overweight adults: a randomised controlled within-subject cross-over trial" via bit.ly/3O07jGF @witte1veronica #Prebiotic #Diet


Free Debrief on HCC with Anna Saborowski, K. Kelley, R. Finn, R. Lencioni, P. Galle on 29th of February Program®istration l1nq.com/188kp Foundation Cancer du Foie

A pleasure to give the annual prize of the Swiss Foundation against Liver Cancer to Dr Melloul and Dr Martin for their work on HCC burden and liver resection. Emmanuel Melloul Foundation Cancer du Foie CHUV / Centre hospitalier universitaire vaudois


Daniel J Drucker Gut Journal Thanks Daniel J Drucker and the Gutsy Journal Gut Journal and Emad El-Omar Dufour for featuring our paper on it's cover --- We can predict MASH resolution with an AUROC of 0.83 using MRI-PDFF, ALT and AST Naga Chalasani Quentin M. Anstee Alina Allen Vijay Shah Chris Thompson, MD




So pumped up to work along Eur. Fdn. for the Study of Chronic Liver Failure Jonel Trebicka vice-secretary EASLnews Debbie Shawcross and Alexander Gerbes about novel therapies and approaches to tackle #aclf. We highlighted U.S. FDA BEST framework to tackle future biomarker development in ACLF ncbi.nlm.nih.gov/books/NBK32679…


1/4 New method thanks to collaboration between #medicine & #physics: a method has been developed and tested at the #unibern and Insel Gruppe that can be used to determine diseased #liver tissue quickly and precisely: sohub.io/b66p Faculty of Medicine, University of Bern Annalisa Berzigotti Schweizerischer Nationalfonds (SNF)

New method of #liver diagnosis, which can be used also for #cancer prevention, developed together with Bern Center for Precision Medicine member Annalisa Berzigotti.

✅ interested in factors modulating cirrhosis regression after control of the etiology? ➡️ Brand new in JHep! Metabolic phenotyping of patients with Advanced Chronic Liver Disease for better characterization of Cirrhosis Regression Yuly Mendoza sciencedirect.com/science/articl…

New #RecentAdvancesInBasicScience paper online by Ha et al on "Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma" via bit.ly/3LctozW #MASLD #HCC The Chinese University of Hong Kong - CUHK CUHK Medicine
